HomepageEarnings Events Newsdesk 3 weeks ago Eversource Energy (ES) Eversource Statement on Proposed Final Decision to Approve Aquarion Sale Eversource Energy (NYSE: ES) FY 2026 Other Release Bristol-Myers Squibb Company (BMY) U.S. FDA Approves Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis » « Incyte Corporation (INCY) Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC) Newsdesk:
